Defining Diabetic Retinopathy Severity

The fundus abnormalities seen in diabetic retinopathy can conceptually be split into three categories – those findings resulting from leaking microvasculature (hemorrhages, lipid exudates, retinal edema); those findings resulting from structural damage to the microvasculature wall (microaneurysms); and those findings resulting from ischemia with a subsequent overproduction of vascular growth factors (cottonwool patches, intraretinal microvascular abnormalities [IRMA], preretinal neovascularization, fibrous proliferation, and vitreous hemorrhage). The severity of each of these findings can be classified and quantified based on the degree of retina involvement, e.g., the number of microaneurysms and hemorrhages in each quadrant or photographic field, the area of retina affected by neovascular tissue or IRMA, the area of macula involved with retinal thickening. Classification schemes are a means to categorize the varying degrees of such findings to facilitate communication.As with all specialized languages, the value of these languages depends upon who is speaking to whom. The ultimate goal of classification schemes is to provide a system to improve patient care. This may be achieved initially by precise communication among researchers to define categories by which the natural history and subsequent response to intervention(s) can be identified. Once these research goals have been achieved these classification schemes should be understandable and reproducible by practicing clinicians. If not, then modification of these classification schemes is desirable to allow clinicians to communicate among themselves and with their patients the expected results of therapies demonstrated to be beneficial in clinical trials. One should realize that the goals of communication between researchers may be different from the goals of communication between clinicians and may likewise be different from the goals of communication between clinician and patient. Evolution of classification schemes is desirable dependent upon who is communicating with whom.

[1]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[2]  Matthew D. Davis,et al.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.

[3]  F. Ferris,et al.  A severity scale for diabetic macular edema developed from ETDRS data. , 2008, Investigative ophthalmology & visual science.

[4]  Matthew D. Davis,et al.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.

[5]  T A Cox,et al.  The importance of fluorescein angiography in planning laser treatment of diabetic macular edema. , 1999, Ophthalmology.

[6]  S. Fine,et al.  Symposium on the treatment of diabetic retinopathy , 1969 .

[7]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[8]  David J Browning,et al.  Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. , 2004, Ophthalmology.

[9]  D. Lackland,et al.  Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. , 2004, Investigative ophthalmology & visual science.

[10]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[11]  Ingrid U Scott,et al.  Diabetic macular edema: what is focal and what is diffuse? , 2008, American journal of ophthalmology.

[12]  N. Bressler,et al.  A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. , 2007, Ophthalmology.

[13]  Linda Huang,et al.  Ultrawide angle fluorescein angiographic imaging: a comparison to conventional digital acquisition systems. , 2008, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[14]  R. Klein,et al.  The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. , 1991, American journal of epidemiology.

[15]  Lloyd Paul Aiello,et al.  Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. , 2007, Archives of ophthalmology.

[16]  F L Ferris,et al.  Photocoagulation for diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, JAMA.

[17]  M. González,et al.  Concordance in diagnosis of diabetic retinopathy by fundus photography between retina specialists and a standardized reading center. Mexico City Diabetes Study Retinopathy Group. , 1995, Archives of medical research.

[18]  A. Patz,et al.  The ETDRS and Diabetes 2000. , 1991, Ophthalmology (Rochester, Minn.).

[19]  David M Nathan,et al.  Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. , 2008, Archives of ophthalmology.

[20]  A. M. Abu El Asrar,et al.  Laser photocoagulation control of diabetic macular oedema without fluorescein angiography. , 1991, The British journal of ophthalmology.

[21]  F L Ferris,et al.  Photocoagulation for diabetic macular edema. , 1987, Archives of ophthalmology.